Meltzer HY - Search Results

1

Marked elevations of serum creatine kinase activity associated with antipsychotic drug treatment.

Meltzer HY, Cola PA, Parsa M. Meltzer HY, et al. Neuropsychopharmacology. 1996 Oct;15(4):395-405. doi: 10.1016/0893-133X(95)00276-J. Neuropsychopharmacology. 1996. PMID: 8887994

2

Plasma clozapine levels and the treatment of L-DOPA-induced psychosis in Parkinson's disease. A high potency effect of clozapine.

Meltzer HY, Kennedy J, Dai J, Parsa M, Riley D. Meltzer HY, et al. Neuropsychopharmacology. 1995 Feb;12(1):39-45. doi: 10.1016/0893-133X(94)00060-D. Neuropsychopharmacology. 1995. PMID: 7766285 Clinical Trial.

3

Plasma clozapine and desmethylclozapine levels in clozapine-induced agranulocytosis.

Hasegawa M, Cola PA, Meltzer HY. Hasegawa M, et al. Among authors: meltzer hy. Neuropsychopharmacology. 1994 Aug;11(1):45-7. doi: 10.1038/npp.1994.34. Neuropsychopharmacology. 1994. PMID: 7945743

4

The pharmacoeconomics of clozapine: a review.

Meltzer HY, Cola PA. Meltzer HY, et al. J Clin Psychiatry. 1994 Sep;55 Suppl B:161-5. J Clin Psychiatry. 1994. PMID: 7961564 Review.

5

Relapse following clozapine withdrawal: effect of neuroleptic drugs and cyproheptadine.

Meltzer HY, Lee MA, Ranjan R, Mason EA, Cola PA. Meltzer HY, et al. Psychopharmacology (Berl). 1996 Mar;124(1-2):176-87. doi: 10.1007/BF02245619. Psychopharmacology (Berl). 1996. PMID: 8935814 Clinical Trial.

6

Age at onset and gender of schizophrenic patients in relation to neuroleptic resistance.

Meltzer HY, Rabinowitz J, Lee MA, Cola PA, Ranjan R, Findling RL, Thompson PA. Meltzer HY, et al. Am J Psychiatry. 1997 Apr;154(4):475-82. doi: 10.1176/ajp.154.4.475. Am J Psychiatry. 1997. PMID: 9090333

7

Cost effectiveness of clozapine in neuroleptic-resistant schizophrenia.

Meltzer HY, Cola P, Way L, Thompson PA, Bastani B, Davies MA, Snitz B. Meltzer HY, et al. Am J Psychiatry. 1993 Nov;150(11):1630-8. doi: 10.1176/ajp.150.11.1630. Am J Psychiatry. 1993. PMID: 8105705

8

Neuropsychologic deficits in schizophrenia: relation to social function and effect of antipsychotic drug treatment.

Meltzer HY, Thompson PA, Lee MA, Ranjan R. Meltzer HY, et al. Neuropsychopharmacology. 1996 Mar;14(3 Suppl):27S-33S. doi: 10.1016/0893-133X(95)00202-O. Neuropsychopharmacology. 1996. PMID: 8866741 Review.

9

The evolution of treatment resistance: biologic implications.

Meltzer HY, Lee M, Cola P. Meltzer HY, et al. J Clin Psychopharmacol. 1998 Apr;18(2 Suppl 1):5S-11S. doi: 10.1097/00004714-199804001-00003. J Clin Psychopharmacol. 1998. PMID: 9555610 Review.

10

Serotonin subtype 2 receptor genes and clinical response to clozapine in schizophrenia patients.

Masellis M, Basile V, Meltzer HY, Lieberman JA, Sevy S, Macciardi FM, Cola P, Howard A, Badri F, Nöthen MM, Kalow W, Kennedy JL. Masellis M, et al. Among authors: meltzer hy. Neuropsychopharmacology. 1998 Aug;19(2):123-32. doi: 10.1016/S0893-133X(98)00007-4. Neuropsychopharmacology. 1998. PMID: 9629566

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

960 results

Search Page

Filters